MedTrace Logo

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10679

Last updated 2021-05-05

No results posted yet for this study

Summary

The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting.

Main objectives are to clarify the:

* treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment)
* Rate of early and late symptomatic VTE recurrence
* Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension
* Rate of bleeding complications
* Rate of all-cause mortality at six months

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Thrombosis Research Institute

    lead OTHER

Principal Investigators

  • Ajay K Kakkar, MD · Thrombosis Research Institute

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-07
Primary Completion
2020-01-04
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155491 on ClinicalTrials.gov